
Emyria
(ASX) EMD
Emyria Financials at a Glance
Market Cap
$38.71M
Revenue (TTM)
$3.95M
Net Income (TTM)
$6.18M
EPS (TTM)
$-0.01
P/E Ratio
-5.85
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Price
$0.05
Volume
338,564
Open
$0.05
Price
$0.05
Volume
338,564
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.02 - $0.08
Dividend
$0.00
Beta (Volatility)
-0.17 (Low)
Price
$0.05
Volume
338,564
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.02 - $0.08
EMD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Emyria
Industry
Pharmaceuticals
Sector
Health CareCEO
Michael Winlo, MD, MBA
Website
emyria.comHeadquarters
Leederville, WA 6007, AU
EMD Financials
Key Financial Metrics (TTM)
Gross Margin
-57%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-59%
Return on Capital
-32%
Return on Assets
-33%
Earnings Yield
-17.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$38.71M
Shares Outstanding
806.56M
Volume
338.56K
Short Interest
0.00%
Avg. Volume
1.28M
Financials (TTM)
Gross Profit
$24.48K
Operating Income
$2.65M
EBITDA
$2.39M
Operating Cash Flow
$2.70M
Capital Expenditure
$13.89K
Free Cash Flow
$2.72M
Cash & ST Invst.
$3.57M
Total Debt
$613.50K
Emyria Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.44M
+32.1%
Gross Profit
$1.33M
+16.6%
Gross Margin
-92.22%
N/A
Market Cap
$38.71M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$2.37M
+78.0%
EBITDA
$2.29M
+82.5%
Quarterly Fundamentals
Net Cash
$9.44M
+1046.4%
Accounts Receivable
$249.55K
+364.1%
Inventory
$0.00
N/A
Long Term Debt
$1.00M
+34.1%
Short Term Debt
$55.30K
-97.5%
Return on Assets
-33.31%
N/A
Return on Invested Capital
-32.07%
N/A
Free Cash Flow
$2.09M
+53.7%
Operating Cash Flow
$2.04M
+54.6%